Over 80 percent of samples have tested positive in Iowa and California.
According to officials, the United States already possesses a national stockpile of approximately 20 million bird flu vaccines that are “well matched” to the H5N1 virus.
If needed, it can also swiftly produce an additional 100 million. Antiviral medications like oseltamivir (Tamiflu), which was used to treat the most recent US bird flu patient in Louisiana, are also available.
The development of a poultry avian flu vaccine and experiments demonstrating that human antivirals would be equally effective on diseased cows are still ongoing.
